Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
21 |
Material Type: Text Resource
|
Capstone Therapeutics Enters Into a Joint Venture for the Development of Apo E Mimetic Peptide AEM28 and Analogs Corporate Conference Call - FinalFair Disclosure Wire, 2012COPYRIGHT 2012 CQ-Roll Call, Inc.Digital Resources/Online E-Resources |
|
22 |
Material Type: Text Resource
|
Event Brief of Bayer Findings from the Phase III ROCKET AF study of Rivaroxaban Conference Call - FinalFair Disclosure Wire, 2010COPYRIGHT 2010 CQ-Roll Call, Inc.Digital Resources/Online E-Resources |
|
23 |
Material Type: Text Resource
|
NANOSPHERE INC at Roth Capital Partners OC Growth Stock Conference - FinalFair Disclosure Wire, 2012COPYRIGHT 2012 CQ-Roll Call, Inc.Digital Resources/Online E-Resources |
|
24 |
Material Type: Text Resource
|
Chinese Smokers Resist Coronary DiseaseMorning Edition, 1997Copyright NPR Sep 1, 1997Digital Resources/Online E-Resources |
|
25 |
Material Type: Text Resource
|
Event Brief of Isis Pharmaceuticals Hosts Expert Panel Conference Call to Discuss Mipomersen Data Presented at the ESC Congress 2010 - FinalFair Disclosure Wire, 2010COPYRIGHT 2010 CQ-Roll Call, Inc.Digital Resources/Online E-Resources |
|
26 |
Material Type: Text Resource
|
U.S. Doctors Help Iraqi Children in JordanAll Things Considered, 2007, p.1(c) 2007 National Public Radio, Inc. All Rights Reserved.Digital Resources/Online E-Resources |
|
27 |
Material Type: Text Resource
|
Event Brief of Isis Pharmaceuticals to Discuss Recent Additions to its Development Pipeline - Conference Call - FinalFair Disclosure Wire, 2011COPYRIGHT 2011 CQ-Roll Call, Inc.Digital Resources/Online E-Resources |
|
28 |
Material Type: Text Resource
|
Isis Pharmaceuticals to Discuss Recent Additions to its Development Pipeline Conference Call - FinalFair Disclosure Wire, 2011COPYRIGHT 2011 CQ-Roll Call, Inc.Digital Resources/Online E-Resources |
|
29 |
Material Type: Text Resource
|
Nanosphere Inc at Stephens Fall Investment Conference - FinalFair Disclosure Wire, 2011COPYRIGHT 2011 CQ-Roll Call, Inc.Digital Resources/Online E-Resources |
|
30 |
Material Type: Text Resource
|
Event Brief of Roche Holding AG ESC 2011 Investor Science Conference Call - FinalFair Disclosure Wire, 2011COPYRIGHT 2011 CQ-Roll Call, Inc.Digital Resources/Online E-Resources |
|
31 |
Material Type: Text Resource
|
Type 2 diabetes, glycaemic traits and cardiovascular disease: a Mendelian Randomization studyDigital Resources/Online E-Resources |
|
32 |
Material Type: Text Resource
|
Study: Statin Drug Reverses Coronary Artery DiseaseAll Things Considered, 2006, p.1(c) 2006 National Public Radio, Inc. All Rights Reserved.Digital Resources/Online E-Resources |
|
33 |
Material Type: Text Resource
|
Isis Pharmaceuticals Hosts Expert Panel Conference Call to Discuss Mipomersen Data Presented at the ACC Annual Scientific Session - FinalFair Disclosure Wire, 2011COPYRIGHT 2011 CQ-Roll Call, Inc.Digital Resources/Online E-Resources |
|
34 |
Material Type: Text Resource
|
IRON LINKED TO CORONARY HEART DISEASEMorning Edition, 1992, p.1Copyright 1992 ;Copyright NPR Sep 9, 1992Digital Resources/Online E-Resources |
|
35 |
Material Type: Text Resource
|
Event Brief of Bayer Review of Rivaroxaban Data Investor Conference Call - FinalFair Disclosure Wire, 2008COPYRIGHT 2008 CQ-Roll Call, Inc.Digital Resources/Online E-Resources |
|
36 |
Material Type: Text Resource
|
Clinton Scheduled To Have Coronary Bypass OperationWeekend Edition Saturday, 2004Copyright NPR Sep 4, 2004Digital Resources/Online E-Resources |
|
37 |
Material Type: Text Resource
|
Event Brief of Isis Pharmaceuticals Hosts Expert Panel Conference Call to Discuss Mipomersen Data Presented at the ACC Annual Scientific Session - FinalFair Disclosure Wire, 2011COPYRIGHT 2011 CQ-Roll Call, Inc.Digital Resources/Online E-Resources |
|
38 |
Material Type: Text Resource
|
Isis Pharmaceuticals Inc RD Day - FinalFair Disclosure Wire, 2012COPYRIGHT 2012 CQ-Roll Call, Inc.Digital Resources/Online E-Resources |
|
39 |
Material Type: Text Resource
|
Event Brief of CV Therapeutics and Astellas Pharma US, Inc. Lexiscan (regadenoson) Injection Approval Conference Call - FinalFair Disclosure Wire, 2008COPYRIGHT 2008 CQ-Roll Call, Inc.Digital Resources/Online E-Resources |
|
40 |
Material Type: Text Resource
|
Juvenile HyperlipemiaVCU. Licensed under a Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported License. http://creativecommons.org/licenses/by-nc-sa/3.0 Acknowledgement of the Virginia Commonwealth University Libraries as a source is required.Digital Resources/Online E-Resources |